Chicken Intestine S9

Chicken Intestine S9

Chicken Intestine S9 fraction is widely used as an in vitro system for drug metabolism and enzyme activity studies.

My Product Summary

Catalog: —

Note:Please select all variant options above.

Estimated Lead Time:

Please select variants

1
Add to Quote

Details


Chicken Intestine S9 is a subcellular fraction containing the complete metabolic enzyme system of the intestine, offering unique advantages in intestine metabolism and toxicity studies. Its comprehensive phase I and phase II metabolic enzyme systems enable a thorough evaluation of the metabolic transformation of drugs in the intestine. As intestine S9 can simultaneously reflect intestine metabolism and detoxification functions, it has become an important model for the safety evaluation of oral drugs. MileCell employs standardized preparation processes to provide active and stable intestine S9 products from various species (such as rat, mouse, dog, monkey, etc.), supporting intestine-specific metabolism research.


Features and Benefits

▪‌Quality Assurance. All batches undergo comprehensive quality control procedures to ensure product integrity and batch-to-batch consistency.

▪‌Comprehensive Characterization. Characterization of key CYP450 and Phase II enzyme activities, ensuring exceptional metabolic performance and specificity for consistent and reliable results.

▪Scalable Production. Large lots derived from intestinal subcellular fractions to minimize lot-to-lot variation and ensure long-term availability across experimental replicates.

▪Available intestine preparations format: PMSF-containing‌ and PMSF-free.

▪Well-Stocked, Fresh & Viable Inventory‌. Customizable: Gender, Species, Vial Size, Batch Size, etc.

Quality


This product is intended for in-vitro research and manufacturing applications only. All biological samples supplied by MileCell, as well as any materials derived from them, are strictly for in-vitro research use. They are not approved or intended for use as source material in clinical therapies.


S9 are provided as a suspension at a concentration of 10 mg/mL. Each vial contains a total volume of 0.5 mL and 0.15 mL. Every production lot is tested for enzymatic activity and metabolic stability to ensure consistent performance.